IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,556,369 | +2732.5% | 327,075 | +1299.7% | 0.01% | – |
| Q2 2023 | $443,291 | +18.8% | 23,368 | -2.8% | 0.00% | – |
| Q1 2023 | $373,046 | -7.5% | 24,052 | +5.8% | 0.00% | – |
| Q4 2022 | $403,511 | +307.6% | 22,733 | +27.4% | 0.00% | – |
| Q3 2022 | $99,000 | +65.0% | 17,837 | +16.4% | 0.00% | – |
| Q2 2022 | $60,000 | -16.7% | 15,327 | +17.6% | 0.00% | – |
| Q1 2022 | $72,000 | -38.5% | 13,034 | -5.3% | 0.00% | – |
| Q4 2021 | $117,000 | -30.8% | 13,768 | -29.3% | 0.00% | – |
| Q3 2021 | $169,000 | -29.3% | 19,462 | -13.9% | 0.00% | – |
| Q2 2021 | $239,000 | -23.6% | 22,617 | +15.8% | 0.00% | – |
| Q1 2021 | $313,000 | -75.5% | 19,523 | -29.4% | 0.00% | -100.0% |
| Q4 2020 | $1,277,000 | – | 27,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |